Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $15.9B |
| FY2017, ended Dec 31, 2017 | $21.1B |
| FY2018, ended Dec 31, 2018 | $19.6B |
| FY2019, ended Dec 31, 2019 | $37.8B |
| FY2020, ended Dec 31, 2020 | $44.3B |
| FY2021, ended Dec 31, 2021 | $90.6B |
| FY2022, ended Dec 31, 2022 | $52.4B |
| FY2023, ended Dec 31, 2023 | $93.6B |
| FY2024, ended Dec 31, 2024 | $126B |
| FY2025, ended Dec 31, 2025 | $114B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $88.3B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $5.15B |
| FY2017, ended Dec 31, 2017 | $7.15B |
| FY2018, ended Dec 31, 2018 | $6.83B |
| FY2019, ended Dec 31, 2019 | $7.34B |
| FY2020, ended Dec 31, 2020 | $6.10B |
| FY2021, ended Dec 31, 2021 | $22.6B |
| FY2022, ended Dec 31, 2022 | $8.52B |
| FY2023, ended Dec 31, 2023 | $8.02B |
| FY2024, ended Dec 31, 2024 | $13.2B |
| FY2025, ended Dec 31, 2025 | $14.5B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $16.1B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.04B | −$110M |
| FY2017, ended Dec 31, 2017 | $1.47B | −$1.65B |
| FY2018, ended Dec 31, 2018 | $1.54B | $27.4M |
| FY2019, ended Dec 31, 2019 | $2.05B | $1.90B |
| FY2020, ended Dec 31, 2020 | $1.05B | $1.82B |
| FY2021, ended Dec 31, 2021 | $5.86B | $3.92B |
| FY2022, ended Dec 31, 2022 | $1.75B | $6.10B |
| FY2023, ended Dec 31, 2023 | $1.39B | $3.83B |
| FY2024, ended Dec 31, 2024 | $2.78B | $3.42B |
| FY2025, ended Dec 31, 2025 | $3.02B | $4.55B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $3.52B | $5.49B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.84B |
| FY2017, ended Dec 31, 2017 | $1.99B |
| FY2018, ended Dec 31, 2018 | $2.21B |
| FY2019, ended Dec 31, 2019 | $2.17B |
| FY2020, ended Dec 31, 2020 | $2.00B |
| FY2021, ended Dec 31, 2021 | $2.12B |
| FY2022, ended Dec 31, 2022 | $4.25B |
| FY2023, ended Dec 31, 2023 | $2.96B |
| FY2024, ended Dec 31, 2024 | $1.97B |
| FY2025, ended Dec 31, 2025 | $2.63B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.51B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $8.94B |
| FY2017, ended Dec 31, 2017 | $15.2B |
| FY2018, ended Dec 31, 2018 | $10.4B |
| FY2019, ended Dec 31, 2019 | $11.5B |
| FY2020, ended Dec 31, 2020 | $5.73B |
| FY2021, ended Dec 31, 2021 | $7.86B |
| FY2022, ended Dec 31, 2022 | $12.5B |
| FY2023, ended Dec 31, 2023 | $11.6B |
| FY2024, ended Dec 31, 2024 | $11.5B |
| FY2025, ended Dec 31, 2025 | $12.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $13.3B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 27.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 588M |
| FY2017, ended Dec 31, 2017 | 659M |
| FY2018, ended Dec 31, 2018 | 659M |
| FY2019, ended Dec 31, 2019 | 676M |
| FY2020, ended Dec 31, 2020 | 684M |
| FY2021, ended Dec 31, 2021 | 700M |
| FY2022, ended Dec 31, 2022 | 706M |
| FY2023, ended Dec 31, 2023 | 715M |
| FY2024, ended Dec 31, 2024 | 729M |
| FY2025, ended Dec 31, 2025 | 742M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 751M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Paid to employees |
|---|---|
| FY2016, ended Dec 31, 2016 | $324M |
| FY2017, ended Dec 31, 2017 | $339M |
| FY2018, ended Dec 31, 2018 | $367M |
| FY2019, ended Dec 31, 2019 | $417M |
| FY2020, ended Dec 31, 2020 | $438M |
| FY2021, ended Dec 31, 2021 | $637M |
| FY2022, ended Dec 31, 2022 | $846M |
| FY2023, ended Dec 31, 2023 | $988M |
| FY2024, ended Dec 31, 2024 | $1.17B |
| FY2025, ended Dec 31, 2025 | $1.45B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.58B |
Valuation
At current price- Market Cap
- $87.6B
- P/E
- 24.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 5.4×
- Price / Book
- 9.7×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $16.1B
- Revenue Growth YoY
- 17.2%
- Revenue CAGR 3Y
- 19.3%
- Revenue CAGR 5Y
- 18.8%
- EPS Growth YoY
- 20.8%
- Net Income Growth YoY
- 22.9%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 47.2%
- Net Margin
- 21.8%
- FCF Margin
- 34.1%
- Return on Equity
- 40.5%
Earnings
Trailing 12 months- Net Income
- $3.52B
- EPS (diluted)
- $4.47
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- $7.60B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $2.51B
- Total Debt
- $13.3B
- Net Debt
- $10.8B
- Total Assets
- $49.9B
- Total Liabilities
- $27.5B
- Shareholders' Equity
- $9.01B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $5.60B
- Capital Expenditure
- $112M
- Free Cash Flow
- $5.49B
Dividends and risk
Last 12 months- Dividend Yield
- 4.5%
- Dividend / Share
- $5.23
- Beta (5Y)
- 1.59
Every ratio is calculated from the company’s reported figures.